Company news
Thalia Therapeutics PLC news in 2025
Thalia Therapeutics PLC's news releases, calls and decks from 2025, newest first.
Business and Operational Update
December 17, 2025
Interim Results
September 25, 2025
Partnership with University of Strathclyde’s CMAC
September 23, 2025
N4 Pharma’s Nuvec® Targets Lung Cancer Cells
September 22, 2025
Notice of Results, Analyst & Investor Presentation
September 19, 2025
Investor Event and Presentation
September 11, 2025
Article on Nuvec®’s Potential in RNA Therapeutics
July 30, 2025
Investor Webinar
July 14, 2025
Directorate Change
July 8, 2025
Result of AGM
June 30, 2025
Insight Event for Retail Investors
June 25, 2025
Final Results, Annual Report and Notice of AGM
June 6, 2025
Establishment of New Senior Leadership Team
May 27, 2025
TR-1: Notification of major holdings
May 23, 2025
Holding(s) in Company
May 21, 2025
N4 101 In Vivo Study Results
May 12, 2025
TR-1: Standard form notification of major holdings
April 23, 2025
Result of General Meeting
April 22, 2025
Posting of Circular and Notice of General Meeting
April 4, 2025
Placing and Subscription to raise £1,750,000
April 1, 2025
N4 Pharma Non-Executive Director Q&A
January 16, 2025
Directorate Changes
January 8, 2025